PFG Investments LLC Acquires 1,261 Shares of MetLife, Inc. (NYSE:MET)

PFG Investments LLC increased its holdings in shares of MetLife, Inc. (NYSE:METFree Report) by 19.8% in the 4th quarter, according to the company in its most recent filing with the Securities & Exchange Commission. The fund owned 7,621 shares of the financial services provider’s stock after buying an additional 1,261 shares during the quarter. PFG Investments LLC’s holdings in MetLife were worth $624,000 at the end of the most recent reporting period.

A number of other hedge funds and other institutional investors have also recently bought and sold shares of MET. UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC grew its holdings in shares of MetLife by 1.5% during the third quarter. UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC now owns 4,548,725 shares of the financial services provider’s stock worth $375,179,000 after purchasing an additional 68,579 shares during the last quarter. Nordea Investment Management AB grew its holdings in MetLife by 16.8% during the 4th quarter. Nordea Investment Management AB now owns 4,238,087 shares of the financial services provider’s stock worth $347,735,000 after acquiring an additional 608,224 shares during the last quarter. Stifel Financial Corp increased its position in MetLife by 5.0% in the 3rd quarter. Stifel Financial Corp now owns 2,239,841 shares of the financial services provider’s stock valued at $184,744,000 after acquiring an additional 105,762 shares during the period. FMR LLC raised its stake in shares of MetLife by 5.4% during the third quarter. FMR LLC now owns 2,209,119 shares of the financial services provider’s stock valued at $182,208,000 after acquiring an additional 112,491 shares during the last quarter. Finally, Swedbank AB lifted its holdings in shares of MetLife by 5.3% during the third quarter. Swedbank AB now owns 1,970,163 shares of the financial services provider’s stock worth $162,499,000 after purchasing an additional 99,328 shares during the period. Institutional investors own 94.99% of the company’s stock.

MetLife Stock Performance

Shares of MetLife stock opened at $86.77 on Thursday. The business has a 50-day simple moving average of $83.95 and a 200 day simple moving average of $80.30. The firm has a market capitalization of $60.08 billion, a price-to-earnings ratio of 17.49, a PEG ratio of 0.65 and a beta of 1.07. The company has a debt-to-equity ratio of 0.51, a current ratio of 0.16 and a quick ratio of 0.16. MetLife, Inc. has a one year low of $64.61 and a one year high of $89.05.

MetLife Dividend Announcement

The company also recently announced a quarterly dividend, which will be paid on Tuesday, March 11th. Investors of record on Tuesday, February 4th will be issued a $0.545 dividend. This represents a $2.18 dividend on an annualized basis and a dividend yield of 2.51%. The ex-dividend date is Tuesday, February 4th. MetLife’s dividend payout ratio is currently 43.95%.

Analysts Set New Price Targets

Several brokerages have commented on MET. Piper Sandler lifted their target price on MetLife from $85.00 to $92.00 and gave the stock an “overweight” rating in a report on Wednesday, October 2nd. Wells Fargo & Company reduced their target price on MetLife from $93.00 to $92.00 and set an “overweight” rating on the stock in a report on Tuesday, January 14th. StockNews.com downgraded shares of MetLife from a “buy” rating to a “hold” rating in a research report on Thursday, January 9th. BMO Capital Markets started coverage on shares of MetLife in a research note on Thursday, January 23rd. They issued a “market perform” rating and a $97.00 price objective on the stock. Finally, Barclays increased their price objective on shares of MetLife from $90.00 to $96.00 and gave the stock an “overweight” rating in a research report on Monday, January 6th. Two investment analysts have rated the stock with a hold rating and twelve have assigned a buy rating to the company. According to MarketBeat.com, the stock currently has an average rating of “Moderate Buy” and a consensus target price of $90.46.

Read Our Latest Research Report on MetLife

MetLife Company Profile

(Free Report)

MetLife, Inc, a financial services company, provides insurance, annuities, employee benefits, and asset management services worldwide. It operates through six segments: Retirement and Income Solutions; Group Benefits; Asia; Latin America; Europe, the Middle East and Africa; and MetLife Holdings. The company offers life, dental, group short-and long-term disability, individual disability, pet insurance, accidental death and dismemberment, vision, and accident and health coverages, as well as prepaid legal plans; administrative services-only arrangements to employers; and general and separate account, and synthetic guaranteed interest contracts, as well as private floating rate funding agreements.

Recommended Stories

Institutional Ownership by Quarter for MetLife (NYSE:MET)

Receive News & Ratings for MetLife Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for MetLife and related companies with MarketBeat.com's FREE daily email newsletter.